Insider Trading January 28, 2026

Live Oak Bancshares CRO Buys Nearly $100,000 of Stock as Q4 Results Outperform

Chief Risk Officer Ewa Maria Stasiowska acquired 2,595.231 shares amid valuation metrics pointing to potential undervaluation

By Nina Shah LOB
Live Oak Bancshares CRO Buys Nearly $100,000 of Stock as Q4 Results Outperform
LOB

Ewa Maria Stasiowska, Chief Risk Officer at Live Oak Bancshares (NASDAQ: LOB), purchased $99,999 of company stock on January 26, 2026. The acquisition coincides with robust fourth-quarter 2025 results and analyst optimism, while InvestingPro data indicates the shares may be trading below Fair Value with a low PEG ratio.

Key Points

  • CRO Ewa Maria Stasiowska bought 2,595.231 shares worth $99,999 on January 26, 2026.
  • Live Oak posted Q4 2025 EPS of $0.95 (66.67% above expectations) and revenue of $172.91 million (14.27% above estimates).
  • InvestingPro flags the stock as trading below Fair Value with a PEG ratio of 0.54; KBW raised its price target to $146 while keeping an Outperform rating.

Ewa Maria Stasiowska, who serves as Chief Risk Officer at Live Oak Bancshares (NASDAQ: LOB), reported an insider purchase of company shares valued at $99,999. According to a Form 4 filed with the Securities and Exchange Commission, the transaction took place on January 26, 2026, and comprised 2,595.231 shares of Voting Common Stock purchased at prices ranging from $38.532 to $38.535 per share.

The acquisition comes as Live Oak Bancshares, a regional bank with a market value of $1.69 billion, has delivered strong stock performance over recent months. InvestingPro data referenced in the filing notes a 16.11% return for the company’s shares over the past six months. InvestingPro analysis further indicates the stock is trading below its Fair Value and shows a PEG ratio of 0.54, a metric that the research service highlights as suggesting potential undervaluation relative to growth expectations.

Insider buying of this magnitude and timing coincides with the company’s most recent financial results. Live Oak Bancshares reported fourth-quarter 2025 earnings per share of $0.95, a figure that exceeded consensus expectations of $0.57 and represented a 66.67% surprise versus the forecast. Revenue for the quarter was $172.91 million, surpassing estimates by 14.27%.

Market reaction to the quarter included a reassessment by at least one sell-side analyst. Keefe, Bruyette & Woods raised its price target for Live Oak Bancshares to $146.00 from $132.00 while maintaining an Outperform rating. The combination of the stronger-than-expected earnings release and the analyst adjustment contributed to a rise in the company’s stock, reflecting increased investor interest following the report.

The Form 4 filing documents the exact quantity and price range of the CRO’s purchase but does not include further commentary from the insider or from company management. The InvestingPro indicators cited in public material point to a potential valuation gap, yet the filing itself contains only the transactional details and the date of the acquisition.

For investors and market participants focused on regional banking and financials, the transaction and the quarter’s results provide observable datapoints: an insider purchase at the end of January, a recent run-up in the stock over six months, and metrics from third-party research suggesting the shares may be priced below intrinsic value. Those monitoring analyst coverage will note the maintained Outperform rating and the higher price target from Keefe, Bruyette & Woods following the quarter.


Summary

Live Oak Bancshares’ CRO purchased $99,999 of company stock on January 26, 2026, acquiring 2,595.231 shares at $38.532 to $38.535 per share. The bank reported a strong Q4 2025, with EPS of $0.95 and revenue of $172.91 million, while InvestingPro data indicates the share price may be below Fair Value with a PEG of 0.54. Keefe, Bruyette & Woods increased its price target to $146.00 and kept an Outperform rating.

Key points

  • Insider activity: CRO Ewa Maria Stasiowska purchased 2,595.231 shares totaling $99,999 on January 26, 2026.
  • Quarterly performance: Q4 2025 EPS of $0.95 beat expectations by 66.67% and revenue of $172.91 million topped estimates by 14.27%.
  • Valuation signals and analyst action: InvestingPro notes the stock trades below Fair Value with a PEG of 0.54; Keefe, Bruyette & Woods raised its price target to $146.00 while maintaining an Outperform rating.

Risks and uncertainties

  • The Form 4 filing includes only transactional details and does not explain the rationale behind the CRO’s purchase, leaving intent and timing interpretation limited to observable facts.
  • Third-party valuation indicators—InvestingPro’s Fair Value assessment and PEG ratio—may differ from other valuation methods and do not guarantee future performance.
  • Analyst price target changes and an Outperform rating reflect professional estimates but are not assurances; market reaction can vary despite strong quarter results.

Risks

  • The Form 4 contains only the purchase details and provides no explanation of the insider’s intentions.
  • Valuation signals from InvestingPro and PEG metrics represent one analytical view and do not ensure future returns.
  • Analyst target revisions and Outperform ratings are estimates that may not prevent stock price volatility.

More from Insider Trading

Elutia director buys $20,800 in Class A shares as company reports revenue gain and Nasdaq notice Feb 2, 2026 Symbotic Accounting Chief Disposes $457,722 in Shares as Company Prices 10M-Share Offering; Goldman Lowers Rating Feb 2, 2026 Wintrust Financial EVP Sells 5,000 Shares as Firm Announces Dividend Hike and Multiple Price-Target Upgrades Jan 30, 2026 Cantor Fitzgerald Affiliates Dispose of Satellogic Shares in $2.94M Transaction Block Jan 30, 2026 Navan Interim CFO Executes $37,044 Sell-to-Cover Transaction Jan 30, 2026